| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Surgery and Pharmacology, University of Arizona College of Medicine (D.W.M.), Tucson, Arizona 85724; Research Service, VA Medical Center (D.W.M.), Tucson, Arizona 85723; Department of Pharmacology and Toxicology, University of North Dakota School of Medicine & Health Sciences (J.S.K., A.R.B.), Grand Forks, North Dakota 58202
Address all correspondence and requests for reprints to: David W. Montgomery, Ph.D., VA Medical Center, Research Service, Department of Surgery, 3601 S. 6th Avenue, Tucson, Arizona 85723.
Prolactin (PRL) is an immunomodulatory hormone which promotes T-cell activation and proliferation. However, the intracellular mechanisms of this action in normal lymphocytes are unknown. Because the PRL receptor (PRLR) activates several signals also activated by the T-cell antigen receptor (TCR)/CD3 complex, we evaluated whether signaling "cross-talk" occurs between these distinct receptors. Using human thymocytes, human peripheral blood lymphocytes and the rat Nb2 lymphoma T-cell, we found that PRL induced rapid phosphorylation of multiple, TCR/CD3 complex proteins, an event required for lymphocyte activation. Two of these phosphorylated proteins were identified to be CD3 epsilon and ZAP-70 tyrosine kinase, molecules essential for TCR function. Further, PRL induced tyrosyl phosphorylation of ZAP-70 in each population of T-lymphocytes tested, demonstrating for the first time that ZAP-70 is a target of PRL action. Taken together, our results suggest that the PRLR directly affects T-lymphocyte activation by means of signaling cross-talk with the TCR/CD3 complex.
This article has been cited by other articles:
![]() |
D W Montgomery Prolactin production by immune cells Lupus, October 1, 2001; 10(10): 665 - 675. [Abstract] [PDF] |
||||
![]() |
D. E. Fleenor and M. Freemark Prolactin Induction of Insulin Gene Transcription: Roles of Glucose and Signal Transducer and Activator of Transcription 5 Endocrinology, July 1, 2001; 142(7): 2805 - 2810. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Savino and M. Dardenne Neuroendocrine Control of Thymus Physiology Endocr. Rev., August 1, 2000; 21(4): 412 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. McAveney, M. L. Book, P. Ling, J. Chebath, and L.-y. Yu-Lee Association of 2',5'-Oligoadenylate Synthetase with the Prolactin (PRL) Receptor: Alteration in PRL-Inducible Stat1 (Signal Transducer and Activator of Transcription 1) Signaling to the IRF-1 (Interferon-Regulatory Factor 1) Promoter Mol. Endocrinol., February 1, 2000; 14(2): 295 - 306. [Abstract] [Full Text] |
||||
![]() |
K. E. Borg, M. Zhang, D. Hegge, R. L. Stephen, D. J. Buckley, N. S. Magnuson, and A. R. Buckley Prolactin Regulation of pim-1 Expression: Positive and Negative Promoter Elements Endocrinology, December 1, 1999; 140(12): 5659 - 5668. [Abstract] [Full Text] |
||||
![]() |
R. K. Agarwal, C.-C. Chan, B. Wiggert, and R. R. Caspi Pregnancy Ameliorates Induction and Expression of Experimental Autoimmune Uveitis J. Immunol., March 1, 1999; 162(5): 2648 - 2654. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |